These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23847367)

  • 1. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
    Cancer Discov; 2013 Jul; 3(7):OF23. PubMed ID: 23847367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
    Maxson JE; Gotlib J; Pollyea DA; Fleischman AG; Agarwal A; Eide CA; Bottomly D; Wilmot B; McWeeney SK; Tognon CE; Pond JB; Collins RH; Goueli B; Oh ST; Deininger MW; Chang BH; Loriaux MM; Druker BJ; Tyner JW
    N Engl J Med; 2013 May; 368(19):1781-90. PubMed ID: 23656643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics of chronic neutrophilic leukemia.
    Maxson JE; Tyner JW
    Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.
    Mohamed A; Gao J; Chen YH; Abaza Y; Altman J; Jennings L; Vormittag-Nocito E; Sukhanova M; Lu X; Chen Q
    Hum Pathol; 2024 Jul; 149():66-74. PubMed ID: 38879086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
    Gotlib J; Maxson JE; George TI; Tyner JW
    Blood; 2013 Sep; 122(10):1707-11. PubMed ID: 23896413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
    Szuber N; Orazi A; Tefferi A
    Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
    Kim SY; Song IC; Kim J; Kwon GC
    Ann Diagn Pathol; 2024 Aug; 71():152317. PubMed ID: 38642470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's different about atypical CML and chronic neutrophilic leukemia?
    Dao KH; Tyner JW
    Hematology Am Soc Hematol Educ Program; 2015; 2015():264-71. PubMed ID: 26637732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form.
    Price A; Druhan LJ; Lance A; Clark G; Vestal CG; Zhang Q; Foureau D; Parsons J; Hamilton A; Steuerwald NM; Avalos BR
    Biochem Biophys Res Commun; 2020 Feb; 523(1):208-213. PubMed ID: 31848046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Tyner JW; Gotlib J
    Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New mutations in myeloproliferative neoplasms; 2014 update].
    Kirito K
    Rinsho Ketsueki; 2014 Oct; 55(10):1833-40. PubMed ID: 25297747
    [No Abstract]   [Full Text] [Related]  

  • 13. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
    Fleischman AG; Maxson JE; Luty SB; Agarwal A; Royer LR; Abel ML; MacManiman JD; Loriaux MM; Druker BJ; Tyner JW
    Blood; 2013 Nov; 122(22):3628-31. PubMed ID: 24081659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically informed therapy in leukemia.
    Radich J
    N Engl J Med; 2013 May; 368(19):1838-9. PubMed ID: 23656651
    [No Abstract]   [Full Text] [Related]  

  • 15. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
    Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW
    Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
    Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y; Qiao C; Chen Y; Zhang SJ
    Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML.
    Bartels S; Lehmann U; Büsche G; Schlue J; Hussein K; Debatin D; Karcher A; Andrulis M; Schirmacher P; Kreipe H
    Ann Hematol; 2015 Jul; 94(7):1255-6. PubMed ID: 25865944
    [No Abstract]   [Full Text] [Related]  

  • 19. Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.
    Maxson JE; Luty SB; MacManiman JD; Abel ML; Druker BJ; Tyner JW
    J Biol Chem; 2014 Feb; 289(9):5820-7. PubMed ID: 24403076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia.
    Spiciarich DR; Oh ST; Foley A; Hughes SB; Mauro MJ; Abdel-Wahab O; Press RD; Viner R; Thompson SL; Chen Q; Azadi P; Bertozzi CR; Maxson JE
    Cancer Res; 2018 Dec; 78(24):6762-6770. PubMed ID: 30348809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.